Rationale for the atrial fibrillation and congestive heart failure (AF-CHF) trial

Cardiac Electrophysiology Review

Volumn 7, Issue 3, 2003, Pages 208-210

  Roy, Denis ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Atrial fibrillation; Congestive heart failure; Rate control; Rhythm control

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CATHETER ABLATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROL STRATEGY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORBIDITY; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SINUS RHYTHM; SURVIVAL; TREATMENT PLANNING;

ATRIAL FIBRILLATION; HEART FAILURE, CONGESTIVE; HUMANS; MULTICENTER STUDIES; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 1342302439     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEPR.0000012383.63580.c8     Document Type: Article

References (28)

1. Bourassa MG, Gurné O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M, Johnstone DE, Yusuf S, for the Studies of Left Ventricular Dysfunction (SOLVD) investigators: Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993;22(Suppl A):14A-19A.
2. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN, for the V-HeFT VA Cooperative Studies Group. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. Circulation 1993;87(Suppl VI):VI-102-VI-110.
3. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN, for the Department of Veterans Affairs CHF-STAT Investigators. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). Circulation 1998;98:2574-2579.
4. Stevenson WG, Stevenson LW. Atrial fibrillation in heart failure [editorial]. N Engl J Med 1999;341:910-911.
5. Waktare JE, Camm AJ. Acute treatment of atrial fibrillation: Why and when to maintain sinus rhythm. Am J Cardiol 1998;81:3C-15C.
6. Lemery R, Brugada P, Cheriex E, Wellens HJ. Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol 1987;60:1406-1408.
7. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: Complete recovery after restoration of sinus rhythm. Am J Med 1988;85;242-244.
8. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-1573.
9. Kieny JR, Sacrez A, Facello A, Arbogast R, Bareiss P, Roul G, Demangeat J-L, Brunot B, Constantinesco A. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J 1992;13:1290-1295.
10. Rodriguez LM, Smeets JL, Xie B, de Chillou C, Cheriex E, Pieters F, Metzger J, den Dulk K, Wellens HJ. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993;72:1137-1141.
11. Gosselink AT, Crijns HJ, van den Berg MP, van den Broek SA, Hillige H, Landsman ML, Lie KI. Functional capacity before and after cardioversion of atrial fibrillation: A controlled study. Br Heart J 1994;72:161-166.
12. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997;30:1039-1045.
13. Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R, Harvey M, Strickberger SA, Man KC, Morady F. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996;78:1433-1436.
14. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Sheinmann MM. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-715.
15. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998;32:197-204.
16. Middlekauf HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-48.
17. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695-703.
18. Maggioni AP, Di Gregorio L, Gorini M, Midi P, Lucci D, Tavazzi L, on behalf of IN-CHF Investigators. Predictors of 1 year mortality in 2086 outpatients with congestive heart failure: Data from Italian network on congestive heart failure. J Am Coll Cardiol 1998:34(Suppl A):218A (Abstract).
19. Matthew J, Hunsberger S, Fleg J, Mc Sherry F, Williford W, Yusuf S, for the Digitalis Investigation Group. Incidence, predictive factors and prognostic significance of supraventricular tachy-arrhythmias in congestive heart failure. J Am Coll Cardiol 1998;34(Suppl A):218A (Abstract).
20. Mahoney P, Kimmel S, De Nofrio D, Wohl P, Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999;83:1544-1547.
21. Crijns HJGM, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, van Veldhuisen DJ. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000;21:1238-1245.
22. Wyse DG, Love JC, Yao Q, Carlson MD, Cassidy P, Greene LH, Martin JB, Ocampo C, Raitt MH, Schron E, Stamato NJ, Olarte A. Atrial fibrillation: A risk factor for increased mortality - an AVID registry analysis. J Interv Card Electrophysiol 2001;5:267-273.
23. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. The Framingham Heart Study. Circulation 2003;107:2920-2925.
24. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
25. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-1424.
26. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-920.
27. The AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation. An AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003;43:20-29.
28. The AF-CHF trial investigators. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The atrial fibrillation and congestive heart failure (AF-CHF) trial. Am Heart J 2002;144:597-607.